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Studies, Rensselaer Polytechnic Institute, Troy, New YorkABSTRACT The aggregation of amyloid-b (Ab) peptides plays a crucial role in the etiology of Alzheimer’s disease (AD).
Recently, it has been reported that an A2T mutation in Ab can protect against AD. Interestingly, a nonpolar A2V mutation
also has been found to offer protection against AD in the heterozygous state, although it causes early-onset AD in homozygous
carriers. Since the conformational landscape of the Ab monomer is known to directly contribute to the early-stage aggregation
mechanism, it is important to characterize the effects of the A2T and A2V mutations on Ab1–42 monomer structure. Here, we
have performed extensive atomistic replica-exchange molecular dynamics simulations of the solvated wild-type (WT), A2V,
and A2T Ab1–42 monomers. Our simulations reveal that although all three variants remain as collapsed coils in solution, there
exist significant structural differences among them at shorter timescales. A2V exhibits an enhanced double-hairpin population in
comparison to the WT, similar to those reported in toxic WT Ab1–42 oligomers. Such double-hairpin formation is caused by
hydrophobic clustering between the N-terminus and the central and C-terminal hydrophobic patches. In contrast, the A2T
mutation causes the N-terminus to engage in unusual electrostatic interactions with distant residues, such as K16 and E22,
resulting in a unique population comprising only the C-terminal hairpin. These findings imply that a single A2X (where X ¼
V or T) mutation in the primarily disordered N-terminus of the Ab1–42 monomer can dramatically alter the b-hairpin population
and switch the equilibrium toward alternative structures. The atomistically detailed, comparative view of the structural land-
scapes of A2V and A2T variant monomers obtained in this study can enhance our understanding of the mechanistic differences
in their early-stage aggregation.INTRODUCTIONAlzheimer’s disease (AD) is the most common form of
dementia, affecting nearly 38 million people worldwide, a
figure that is predicted to double over the next 20 years.
The pathological hallmarks of AD are the aberrant deposi-
tion of extracellular senile plaques comprised of amyloid-
b (Ab) peptides and intracellular neurofibrillary tangles
(1). Proteolytic cleavage of the amyloid precursor protein
generates Ab peptides of different lengths (39–43 residues),
among which Ab1–40 and Ab1–42 are the major isoforms,
with Ab1–42 being more aggregation-prone and toxic than
Ab1–40 (2). The molecular process underlying AD, as out-
lined in the amyloid b hypothesis, involves an imbalance
between production and clearance of Ab. This imbalance
results in accumulation of amyloid plaques comprised of
Ab aggregates. The abnormal aggregation of Ab peptides
into b-sheet-rich fibrils involves a heterogeneous ensemble
of oligomeric intermediates, all of which are found to be
neurotoxic (3). Ab toxicity originates from a number of
factors, including formation of ion channels (4), oxidative
stress (5), and interaction with receptors (6). NMR studies
(7–10) suggest that Ab1–42 fibrils model as parallel-stackedSubmitted October 2, 2014, and accepted for publicationDecember 4, 2014.
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0006-3495/15/02/0738/10 $2.00hairpin-like structures. The hydrophilic N-terminus (resi-
dues 1–16) appears unstructured in those fibril structures,
whereas the two hydrophobic patches (residues 17–20 and
30–40) form U-shaped conformations comprised of two
intermolecular, parallel, in-register b-sheets separated by a
hydrophilic turn region (residues 22–29).
Most proposed pathways for the initial stages of Ab am-
yloid fibril formation suggest some conformational change
(misfolding) of the intrinsically disordered Abmonomer, re-
sulting in an activated monomer that then recruits other Ab
molecules to form low-n oligomers (11). Based on the pro-
tease-resistant nature of residues A21–A30, this region was
proposed as the nucleus site for Ab monomer misfolding
(activation) (12). A link between monomer misfolding and
aggregation propensity and toxicity has been proposed
based on experiments (13–16) and simulations (17–26) of
the naturally occurring alloforms. Those alloforms contain
substitutions that occur mainly within the turn region (resi-
dues 22–30). Because of the disordered structure of the
N-terminus in the fibril structure, the role of this region in
aggregation, toxicity, and pathogenesis was considered for
a long time to be negligible (27) and therefore remained
largely unexplored. However, several recent reports indicate
the possible importance of the N-terminus in Ab structure,
association, and toxicity (28–30). A novel structural motifhttp://dx.doi.org/10.1016/j.bpj.2014.12.013
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reported with minimal exposure of hydrophobic residues, in
which association was found between the N-terminus and
residues 17–22 (31). Antibodies that specifically bind to
the N-terminus are known to effectively interact with both
soluble and insoluble forms of Ab (32). Amyloid inhibitor
tetrapeptides are also known to bind at the Ab N-terminus
(33). Two N-terminal mutations, English (H6R) and Tottori
(D7N), are reported to alter the monomer misfolding and
produce oligomers that are toxic compared with the wild-
type (WT) (16). A few recent studies have also suggested
the importance of the extreme N-terminus. Experiments re-
ported delayed assembly kinetics and compactness of the
D1Y-substituted Ab40/42 peptides (34) and higher toxicity
of an A2F variant (35), a consequence of a more hydropho-
bic N-terminus. It is known that the double mutation D1E/
A2V affects Ab1–40 fibrillation (36). Pyroglutamate-modi-
fied Ab (Ab(pE3-42)) peptides have also emerged as poten-
tial key factors in AD pathology due to their abundance in
the AD brain, high aggregation propensity, stability, and
cellular toxicity (37). A familial A2V mutation has been re-
ported to cause dementia in homozygous carriers, whereas
heterozygous carriers were found to be protected (38).
The co-incubation of WT and A2V Ab1–42 peptides was
shown to inhibit toxicity in the same study (38). The A2V
Ab1–42 also has been shown to have a very different aggre-
gation pathway involving annular oligomers with higher
hydrophobic exposure and stronger toxicity compared to
the WT; the A2V peptides more rapidly formed a structured
oligomer, as demonstrated by dynamic light-scattering
experiments (39).
Recently, a rare A2T variant was found to protect against
AD and cognitive decline in the elderly without AD (40).
This is thought to represent the first example of an Ab
variant that confers protection against AD. The prevailing
hypothesis for its protective action is that the mutation
(A673T in the amyloid precursor protein or A2T in Ab),
close to the b-secretase cleavage site, lowers Ab pro-
duction, thereby balancing production with clearance.
However, the reported lowering in production was a mod-
erate 20% in heterozygous carriers (40). The downstream
effects of this mutation could also be vital to its protective
behavior (41).
The effects of the A2V and A2T mutations on Ab aggre-
gation and toxicity have just started to emerge, and reports
appear somewhat controversial. Two recent studies that em-
ployed thioflavin T (ThT) fluorescence monitoring suggest
very different effects of the A2T mutation on Ab1–42 aggre-
gation (42,43). Benilova et al. showed no change in Ab1–42
aggregation upon either A2T or A2V mutation (43). On
the other hand, the results from Maloney et al. suggested
a lower aggregation propensity of A2T Ab1–42 when
compared to both WT and A2V with similar aggregation
profiles (42). In the context of Ab1–40, A2T has been shown
to aggregate faster (43,44) or similarly (42) compared toWT. On the other hand, A2V Ab1–40 exhibited faster
aggregation than the WT (38,42,43). The effects of those
mutations on aggregation also have been analyzed in
combination with the WT peptide. Although 1:1 mixture
of WT/A2V Ab1–42 showed intermediate aggregation
compared to the pure solutions in a study by Messa et al.
(39), the same mixture was reported by Benilova and col-
leagues (43) to demonstrate fast aggregation similar to
that observed for WT Ab1–42. The latter group reported
that a 1:1 WT/A2T mixture exhibited no change in aggrega-
tion kinetics (43), but Maloney et al. found an intermediate
effect (42).
Maloney et al. (42) also compared the toxicity of WT,
A2V, and A2T peptides to cultured neurons and found that
WT and A2T peptides exhibited similar toxicity, whereas
A2V had somewhat lower toxicity. This is to some extent
counterintuitive and contradictory to what was reported
for the A2VAb1–42 by Di Fede et al. (38). Taken together,
the effects of A2V and A2T mutations on early aggregation
and toxicity are still not fully clear and seem to be very
different depending on the isoform (Ab1–40 versus Ab1–42)
and experimental conditions. It is also possible that the
current experiments are not sensitive enough to capture
the effects of those mutations in the more hydrophobic,
aggregation-prone, and toxic Ab1–42 isoform.
Given the protective and causative effects associated with
the A2V and A2T substitutions and the established link be-
tween monomer misfolding and early aggregation, it is
crucial to obtain a comparative view of the conformational
landscapes of those two variants and the WT Ab1–42 full-
length monomers. Even with the sophistication of modern
techniques, experimental characterization of the monomeric
Ab peptides remains challenging due to the intrinsically
disordered and rapidly interchanging nature of the system.
On the other hand, molecular dynamics (MD) simulations
at different resolutions have been widely used to comple-
ment experiments (45) in providing detailed information
on the structure of various Ab species ranging from mono-
mers (23,46–50) to oligomers (51,52) to protofibrils (53) to
fibrils (54). Interactions of different Ab species with toxicity
and aggregation inhibitors (55–57) and with lipid bilayers
(58,59) also have been studied using MD. In this study,
we have performed extensive all-atom replica-exchange
molecular dynamics (REMD) simulations of WT, A2V,
and A2TAb1–42 in explicit water to characterize the mono-
meric ensemble. To our knowledge, this is the first study
comparing the structural landscapes of the A2T and A2V
Ab1–42 monomers. Our simulations reveal an enhanced dou-
ble-hairpin population in A2V due to hydrophobic clus-
tering between the N-terminus and distant hydrophobic
patches. In contrast, the A2T mutation engages the N-termi-
nus in an unusual set of long-range electrostatic interactions
with residues such as K16 and E22, resulting in a population
of unique conformations that comprise only the C-terminal
hairpin. These findings imply that the A2X (X ¼ V or T)Biophysical Journal 108(3) 738–747
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can dramatically alter the WT monomeric conformational
landscape by globally rewiring the intramolecular interac-
tion network within Ab1–42.MATERIALS AND METHODS
Details of the MD simulations regarding system setup, simulation parame-
ters, simulation length, and so forth can be found in the Supporting Mate-
rial. The total number of replicas used was 64, and each replica was 175 ns
long, resulting in an aggregate simulation time of 11.2 ms per system. A
number of convergence checks were performed (see the Supporting
Material).RESULTS
In this work, we compare in silico the monomeric conforma-
tional ensemble of the A2V and A2T Ab1–42 variants with
that of WT by performing extensive atomistic REMD simu-
lations in explicit water. All three variants exhibit similar
secondary structure propensity, with coils and turns being
prevalent (see Fig. S3 a in the Supporting Material).
The secondary-structure propensity values for WT are
~30% coil, ~45% turn, and ~18% b-strand; A2V and A2T
show similar values. This estimated composition for the
WT system in this study agrees well with an earlier report
(20), implying that the sampling obtained using the protocol
described here represents the WT monomeric structureFIGURE 1 Secondary and tertiary structure. (Top) Secondary structure per res
Colors used are shown on the right. The standard deviations were estimated by sp
A2V, and (f) A2T. (Upper triangle) Ensemble-averaged probability of interresidu
shown) are colored according to the color map shown on the right. (Lower triang
Ab variants colored according to the color map shown on the right. Black dotted
contacts involving residues 1–5, which help discriminating the variants. To see
Biophysical Journal 108(3) 738–747reasonably and consistently well. The ensemble-averaged
secondary structure per residue for each variant is shown
in Fig. 1, a–c. The residue-based secondary-structure pro-
pensity analysis (Fig. 1, a–c) suggests a primarily disordered
N-terminal region (residues 1–15) for all three variants, with
a strong turn character around residues 8–9 and 13–15 and a
small (5–10%) b-strand propensity in the first 12 residues.
Some helical structure near residues 12–16 is also observed.
Residues 17–20 (the central hydrophobic cluster (CHC))
and 31–40 show high b-strand propensity (R25%) in addi-
tion to a predominant turn around residues 23–30 in the WT
(Fig. 1 a), consistent with the reported strand-loop-strand
(SLS) structure of Ab10–35 (60). Interestingly, A2V demon-
strates higher b-strand propensity within residues 16–20,
30–35, and 39–41 compared with the WT. A significant in-
crease in the turn propensity compared to theWTalso can be
noticed in residues 23–30 and 36–37 of A2V (Fig. 1 b). On
the other hand, the b-strand propensity is found to be lower
in A2T around residues 18–19, 31–32, and 36–39 (Fig. 1 c).
In addition, the turns around residues 23–30 and 36–37
appear more prominent in A2T. These data indicate that a
mutation in the extreme N-terminus (at position 2) can alter
the secondary structural preference of the distant hydropho-
bic regions (the CHC and the C-terminus).
The Ca-contact map (Fig. 1 d, upper triangle) reveals the
presence of strong antidiagonal contacts between the CHC
and C-terminus, suggesting a b-hairpin formation in theidue averaged over the production ensemble: (a) WT, (b) A2V, and (c) A2T.
litting the data in four equal sets. (Bottom) Tertiary contact maps: (d) WT, (e)
e Ca-Ca contact formations (nonsequential contacts, i.e. ji-jjR3, are only
le) Arithmetic difference between the contact probabilities for each pair of
circles highlight the two sets of antidiagonal contacts as well as the crucial
this figure in color, go online.
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mation of residues 17–36 during early Ab aggregation has
been further supported by an affibody-Ab complex structure
(61) and by the presence of a turn-like structure at residues
25–29 in Ab oligomers (62). Additional antidiagonal con-
tacts appear prevalent in the C-terminal region between res-
idues 33–36 and 39–41, indicative of a second b-hairpin
motif. These results imply a double-hairpin topology, in
agreement with the simulations performed by Rosenman
et al. (20). Long-range interactions between two termini
(residues 1–8 and 32–42) are observed in addition to some
contacts between the CHC and the extreme N-terminus (res-
idues 1–5). Highly probable local contacts consistently
appear in the turn regions.
Fig. 1 e (upper triangle) reveals a more robust nature of
those b-hairpin interactions in A2V compared to the WT,
suggesting a favored population of double-hairpin struc-
tures in A2V. The long-range interactions between the
N-terminus (residues 1–4) and the CHC are stronger in
A2V (Fig. 2 b, upper triangle) compared with the WT.
The difference contact map (Fig. 1 d, lower triangle)
further reveals a register shift toward the N-terminus in
A2V compared with the WT for both sets of antidiagonal
interactions.In the A2T variant (Fig. 1 f, upper triangle), the antipar-
allel b-hairpin interactions between the CHC and residues
30–35 are weaker than in the WT, whereas the C-terminal
b-hairpin appears more robust. Also, a cluster of contacts
between residues 5–7 and the CHC is observed in A2T.
Interactions between residues 1–4 and 34–42 appear weaker
in A2T than in the WT (Fig. 1 f, lower triangle). However,
residues 1–4 of A2T make contact more frequently with the
23–30 turn (Fig. 1 f, lower triangle, dashed circle); in gen-
eral, those contacts are weak. At least 25% of those contacts
occur with a R10% probability for the A2T variant,
compared to 7% probability in the WT and A2V. Taken
together, these results suggest that the A2V/T substitution
primarily alters 1) the b-hairpin interactions between the
CHC and the C-terminus, termed NCCHC-CTR and 2) the
interactions between the N-terminus (Ntr) (residues 1–5)
and the CHC, termed NCNtr-CHC.
In the following, we compare the potential mean force
(PMF) plots (Fig. 2) to discriminate between the conforma-
tional ensembles of different variants. It should be noted
that as all three peptides are intrinsically disordered, it is
nontrivial to choose an optimal set of reaction coordinates
for defining their free-energy landscapes. Since from the
above analysis, the two sets of contacts, namely NCNtr-CHCFIGURE 2 Potential of mean force (PMF) plots:
(a) WT, (b) A2V, and (c) A2T. Two-dimensional
PMF plots as a function of number of contacts be-
tween the Ntr (residues 1–5) and the CHC (residues
16–21), NCNtr-CHC, and number of contacts be-
tween the CHC and the C-terminal region (residues
31–42), NCCHC-CTR. Each contour level represents
0.5 kcal/mol. White squares denote the discrete
regions on the PMF plots individually represen-
ting R5% of the production ensemble. The repre-
sentative conformation of the largest cluster for
each of those regions is shown using cartoon repre-
sentation colored with a red-to-blue rainbow spec-
trum from the N- to C-terminus. Residue 2 is shown
in purple spheres, whereas the residues forming
long-range contacts with the N-tr are shown using
CPK representation. A 5 A˚ cutoff between heavy
atoms is used for this purpose. The residues are
colored according to their types (hydrophobic,
gray; polar, green; basic, blue; acidic, red). To
see this figure in color, go online.
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tertiary contact probabilities among variants, we estimated
the PMFs as a function of them (see the SupportingMaterial).
The WT PMF plot reveals distinct features of the most popu-
lated regions (regions S1–S3) (Fig. 2 a, white boxes) of the
landscape. The S1 region corresponds to the structures with
strongly limited NCNtr-CHC and NCCHC-CTR contacts. Struc-
tures with robust CHC-CTR interaction accompanied by
a few (%5) Ntr-CHC contacts populate the S2 region.
In contrast, S3 conformations exhibit stronger Ntr-CHC
interaction but lack substantial CHC-CTR contacts, and
they are much less populated (compared to S1 and S2). We
also performed a cluster analysis with a 3 A˚Ca-RMSD cutoff
distance on those discrete regions. The definition criteria,
population size, and cluster analysis results for those regions
are listed in Table S1, demonstrating that those structures all
together represent >75% of the total ensemble for each sys-
tem. The total number of clusters and the size of the top five
clusters show that the S1 structures are more disordered than
S2 structures, whereas S3 can be well represented by a single
cluster. The representative structure for the largest cluster of
each region is shown in Fig. 2 a. Additional representative
structures, as well as the tertiary contact maps and the resi-
due-based secondary-structure propensities, can be found inFIGURE 3 Analysis of the A2V conformations with enhanced Ntr-CHC inte
maps for A2V conformations corresponding to the S3 (left), S4 (middle), and S5
triggered by Ntr-CHC contacts. Color schemes used are the same as in Figs. 1 an
To see this figure in color, go online.
Biophysical Journal 108(3) 738–747Fig. S4. Those data confirm that the WT S1 conformations
are mostly disordered and show very little secondary and ter-
tiary structure (Fig. S4 a). The only structured region in the
S1 conformations is the C-terminus, with a 20% b-hairpin
population. In contrast, both sets of hairpin contacts are
evident in S2 structures, the C-terminal hairpin being slightly
weaker than the CHC-CTR one (Fig. S4 b). Interestingly, the
minor S3 population consists of interaction of the 23–30 turn
with both termini, which is absent in S1 and S2 structures
(Fig. S4 c). Representative conformations illustrated in
Figs. 2 a and S4 support these results.
The S1 and S2 regions in A2V (Figs. 2 b and S5, a and b)
and A2T (Figs. 2 c and S6, a and b) monomers show similar
features overall when compared to the WT. Interestingly,
A2V samples additional structures containing significant
Ntr-CHC and CHC-CTR interactions (Fig. 2 b, S4 and S5
regions); such conformations are rarely observed for the
WT and A2T. The representative structures from those
regions imply that a nonpolar amino acid at position 2
(i.e., Val) forms a hydrophobic cluster involving hydro-
phobic side chains from CHC, resulting in further stabiliza-
tion of CHC-CTR contacts (Fig. 2 b). Accordingly, the
secondary-structure analyses and tertiary contact maps for
S4 and S5 structures (Fig. 3, middle and right) revealraction. The residue-based secondary structure and tertiary Ca-Ca contact
(right) regions. S4 and S5 structures demonstrate double-hairpin topology
d 2. The top arrow indicates the relative probability of Ntr-CHC interaction.
FIGURE 4 Unique A2T conformations with altered ionic network. (a)
Residue-based secondary structure, (b) tertiary Ca-Ca contact map, and
(c) ionic network within the representative conformation of the largest S3
cluster. The residues, i.e., D1, E3, R5, K16, and E22, forming long-range
ionic interaction, are shown using licorice representation. Hydrogen bonds
A2V and A2T Ab1–42 Monomeric Ensemble 743double-hairpin-like conformations. Those conformations
are regularly populated in A2V (S4 þ S5 represent 15%
of the total ensemble (Table S1)), as compared with the
WT. Lowering of disorder can be seen in those double-
hairpin conformations, as revealed from the total number
of clusters and the size of the top five clusters (Table S1).
Fig. 3 further shows that both sets of hairpin interactions
experience a subtle register shift toward the N-terminus in
a subpopulation of those double-hairpin structures (the S4
region). The Ntr-CHC contacts are also found in the S3
structures of A2V; however, in those structures, the C-termi-
nus remains in a collapsed coil structure (Fig. 3, left).
In sharp contrast, A2T more frequently visits conforma-
tions with significant Ntr-CHC interaction but much weaker
CHC-CTR contacts (Fig. 2 c, S3 region). Interestingly, this
region of the landscape is rarely populated for both WT and
A2V, but the population for A2T is a significant 17% of the
total ensemble (Table S1). Further analysis reveals a weaker
CHC-CTR interaction resulting in the loss of the first
hairpin present in those unique S3 structures (Figs. 2 c
and 4, a and b). Consequently, those structures contain
only the C-terminal b-hairpin (Fig. 4, a and b). The side-
chain-side-chain contact map illustrates strong interaction
between the N-terminus (residues 1–6) and residues 16–
22 (Fig. S7); however, residue T2 appears to be weakly
involved in those interactions and remains solvent-exposed.
In particular, strong D1-K16 and R5-E22 side-chain-side-
chain contacts are observed. Accordingly, the representative
structure illustrates an ionic network comprised of residues
D1, E3, R5, K16, and E22 (Fig. 4 c). The salt-bridge
population analysis (Table S2) indicates that such ionic
interaction becomes more probable in the presence of a
solvent-exposed threonine at position 2. For example, the
D1-K16 salt bridge is populated with a probability of 34%
in S3 structures. At the same time, the formation of the
E22-K28 salt bridge becomes less probable (5% (Table
S2)) in S3 structures compared to what is observed in S1
and S2 (35% and 12% probabilities, respectively). Taken
together, the altered ionic network between the N-terminus
and distant charged residues, such as K16 and E22, appears
to hinder the formation of the first hairpin interaction in the
S3 structures of A2T.are shown in black dotted lines. Residue Thr2 is shown in purple. Color
schemes used are the same as in Figs. 1 and 2. To see this figure in color,
go online.DISCUSSION
Given the reported protective and causative effects associ-
ated with A2V and A2T substitutions vis a` vis AD, it is of
importance to understand the differences in the self-assem-
bly process of those variant peptides, which is intimately
associated with the disease pathogenesis. The first step
toward this goal is to characterize the conformational land-
scapes of those variant monomers and compare them with
the WT. To our knowledge, this is the first study to compare
the structural landscapes of the A2T and A2V Ab1–42
monomers. Our findings from extensive REMD simulationsreport significant differences in terms of the transient struc-
ture population in those variants, which is modulated by
interactions of the N-terminus with hydrophobic residues
(the CHC) in the case of A2V or with charged residues
(K16 and E22) in the case of A2T.
The more persistent b-hairpin character in the hydropho-
bic regions that lead to a double-hairpin topology in the
A2V monomer, as revealed in our simulations, could have
important implications in determining the aggregation andBiophysical Journal 108(3) 738–747
FIGURE 5 Schematic illustration of the Ab1–42 N-terminus influence
on the monomeric landscape. The curves show free energy of the variant
monomers in one dimension. Based on the analysis, the reaction coordinate
might represent a combination of the CHC-CTR interaction and Ntr-peptide
interaction. The N-terminal substitution, depending on its hydrophobic or
polar nature, can switch the relative population among different b-hairpin
conformational states present in the WT landscape. It should be noted
that this is an overly simplified representation of the Ab1–42 landscape,
and many other conformational states are present due to the intrinsically
disordered nature of the system. To see this figure in color, go online.
744 Das et al.toxicity of A2V. This monomer has been reported to follow
a peculiar aggregation behavior that leads to the formation
of annular structures with a higher hydrophobicity profile
and hence higher toxicity in vitro (39) as well as in vivo
(63). A2V also showed greater b-conformation propensity
during aggregation (64). The formation of b-structures is
believed to be important in amyloid aggregation and
toxicity. For example, b-hairpin monomeric conformations
in amyloid peptides are found to represent metastable states
that interconvert slowly and thus can act as the seed
for nucleation (65). Experiments have also highlighted
the importance of b-hairpin stabilization in the Abmonomer
in inducing a toxic soluble oligomer population (61,66,67).
NMR and atomic force microscopy (AFM) experiments
(68) have suggested the presence of double-hairpin confor-
mations within toxic Ab1–42 oligomers. Double-cysteine
mutants (Ab40cc and Ab42cc) with overly stable b-hairpin
monomeric conformation have been shown to lower fibril
formation and increase populations of toxic b-sheet oligo-
mers and/or protofibrils (67). A structural comparison of
monomeric Ab1–42 and fibrillar Ab1–42 suggests that the
monomeric hairpin conformation needs to retain sufficient
flexibility to undergo a concerted conformational change to-
ward the extended parallel b-sheet structure found in fibrils
(61), as also observed in MD simulations of Ab10–35 dimers
and trimers (66). The fact that double-hairpin structures
were only observed in Ab1–42 and not in Ab1–40 has been
linked to the higher aggregation propensity and toxicity of
the longer isoform (20). Taken together, our simulations,
combined with results of previous studies, imply that the
transiently formed double-hairpin structures of the A2V
monomer might contribute to the stabilization of small,
toxic oligomers composed of b-structures, thus inhibiting
fibrillation. Thus, a single-point nonpolar substitution at po-
sition 2 of Ab1–42 might act as a switch to redirect the pep-
tides to aggregate via a neurotoxic pathway by stabilizing
the b-hairpin conformation (Fig. 5). Our results are consis-
tent with simulations of the shorter A2VAb1–28 monomer,
which indicated that a valine at position 2 can favor
Ntr-CHC interaction (69). Nevertheless, the simulations of
the full-length A2V peptide presented here demonstrate
how the hydrophobic Ntr-CHC interaction can lead to
enhanced CHC-CTR hairpin population, leading to the
double-hairpin topology (Fig. 5).
Our simulations further suggest a competition between
specific hydrophobic and electrostatic interactions modu-
lated by the N-terminus within the Ab1–42 monomer, which
in turn regulates the delicate balance among the local
minima present in its frustrated conformational landscape
(Fig. 5). As discussed above, the N-terminus in the A2V
variant stabilizes the double-hairpin conformation by
clustering with distant hydrophobic residues (Fig. 5). In
contrast, the A2T variant, with its more polar N-terminus,
leads to unique structure populations that are rarely seen
for the WT and A2V. Although Thr-2 itself minimally inter-Biophysical Journal 108(3) 738–747acts with the rest of the protein in those conformations, its
presence allows the N-terminus (e.g., residues D1, E3, and
R5) to form an unusual set of ionic interactions with distant
residues, such as K16 and E22. This effect impairs the
formation of the E22-K28 salt-bridge that is known to be
crucial for CHC-CTR hairpin formation (18). In conse-
quence, those structures comprise only the C-terminal short
b-hairpin (Fig. 5).
Mutations at residues E22 (E22K, E22G, and E22Q) and
D23 (D23N) that affect Ab aggregation and cause early-
onset AD (15) are reported to alter the WT 21–30 turn
structure in simulations (70). Two N-terminal mutations
(H6R and D7N) also have been found to affect the extent
of b-structure and salt-bridge network within the monomer
(71,72). Nevertheless, those mutations directly change the
charge distribution within the peptide, which is not the
case for A2T. At first glance, a threonine at position 2 would
not be expected to have a dramatic effect on the Ab1–42
conformational landscape by altering the electrostatic
interaction network. It appears that Thr-2 changes the local
conformational preference of the N-terminus, consequently
promoting alternative electrostatic interactions that compete
with those required for turn nucleation and CHC-CTR
hairpin formation. This leads to population of rare and
unique conformations (S3 structures). Since b-hairpin abun-
dance has been linked with aggregation mechanisms and
toxicity associated with AD (17,73), the unique A2T confor-
mations devoid of the CHC-CTR b-hairpin that also have an
altered electrostatic interaction network might contribute
toward its slower aggregation (42). It is noteworthy that a
threonine in position 2 appears to introduce more disorder
within Ab1–42, whereas a valine at the same position induces
some order, which overall is consistent with the intrinsic
(dis)order-promoting nature of those amino acids (74).
However, our simulations reveal that this effect arises
from the global interaction changes triggered by a single
A2V and A2T Ab1–42 Monomeric Ensemble 745amino acid substitution. Interestingly, conformation-spe-
cific antibody staining experiments imply the involvement
of the N-terminus in tertiary interactions in the oligomers
of both A2Vand A2T variants (43). Our simulations demon-
strate that such an interaction is also present at the monomer
level and is strikingly different between the two variants,
which might play a critical role in their early aggregation
by populating different monomer structures. Since the Ab
N-terminus also has been suggested to be crucial in binding
with membrane (75) and with some toxic Ab receptors (76),
the altered interaction pattern observed in the A2Vand A2T
monomers may also affect their toxicity (77).
If the interaction between the extreme N-terminus and the
rest of the peptide is indeed critical for aggregation and
toxicity, then it may be possible, for example, to use small
organic molecules (78) and peptides (79,80) that would
bind to Abmonomers and/or oligomers and inhibit aggrega-
tion and/or toxicity by intervening in or altering this inter-
action. The role of the extreme N-terminus in modulating
the Ab1–42 monomeric hairpin structure revealed here may
guide the design of inhibitory peptides, including variants
of the WT (1DAEFRH6) sequence (64).CONCLUSIONS
Taken together, our findings suggest that the effect of
the second amino acid on the Ab1–42 monomer structure is
highly complex and sequence-dependent. An enhanced dou-
ble-hairpin population similar to those reported in toxic WT
Ab1–42 oligomers is found in the A2V monomer. Hydro-
phobic clustering between the N-terminus and the central
and C-terminus hydrophobic patches promotes such dou-
ble-hairpin formation in A2V. In contrast, the A2T mutation
triggers unusual ionic interactions of the N-terminus with
K16 and E22, thereby impeding CHC-CTR hairpin forma-
tion. Consequently, a unique population comprising only
the C-terminal hairpin is observed. Although further inves-
tigation is needed to obtain a complete molecular picture of
the relationship between monomer misfolding, aggregation,
and toxicity, and protection against or causation of AD by
these N-terminal variants, the simulations described here
clearly show that single A2Vand A2T substitutions can alter
the structural landscape of the Ab1–42 monomer by shifting
the equilibrium to different conformational states.SUPPORTING MATERIAL
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